• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

II类主要组织相容性复合体成熟过程中一种中间体的结构:与HLA-DR3结合的CLIP

The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.

作者信息

Ghosh P, Amaya M, Mellins E, Wiley D C

机构信息

Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA.

出版信息

Nature. 1995 Nov 30;378(6556):457-62. doi: 10.1038/378457a0.

DOI:10.1038/378457a0
PMID:7477400
Abstract

A complex between HLA-DR3 and a fragment of invariant chain called CLIP was isolated from a human cell line defective in antigen presentation and its X-ray crystal structure determined. Previous data indicate that this complex is an intermediate in class II histocompatibility maturation, occurring between invariant chain-DR3 and antigenic peptide-DR3 complexes. The structure shows that the CLIP fragment binds to DR3 in a way almost identical to that in which antigenic peptides bind class II histocompatibility glycoproteins. The structure is the substrate for the loading of antigenic peptides by an exchange process catalysed by DM.

摘要

从一个抗原呈递缺陷的人类细胞系中分离出了一种HLA - DR3与一种名为CLIP的恒定链片段的复合物,并确定了其X射线晶体结构。先前的数据表明,这种复合物是II类组织相容性成熟过程中的一个中间体,出现在恒定链 - DR3复合物和抗原肽 - DR3复合物之间。该结构显示,CLIP片段与DR3的结合方式几乎与抗原肽与II类组织相容性糖蛋白的结合方式相同。该结构是由DM催化的交换过程中抗原肽加载的底物。

相似文献

1
The structure of an intermediate in class II MHC maturation: CLIP bound to HLA-DR3.II类主要组织相容性复合体成熟过程中一种中间体的结构:与HLA-DR3结合的CLIP
Nature. 1995 Nov 30;378(6556):457-62. doi: 10.1038/378457a0.
2
Variation in HLA-DM expression influences conversion of MHC class II alpha beta:class II-associated invariant chain peptide complexes to mature peptide-bound class II alpha beta dimers in a normal B cell line.HLA-DM表达的变化影响正常B细胞系中MHC II类αβ:II类相关恒定链肽复合物向成熟的肽结合II类αβ二聚体的转化。
J Immunol. 1996 Mar 15;156(6):2196 - 2204.
3
Flexibility of the MHC class II peptide binding cleft in the bound, partially filled, and empty states: a molecular dynamics simulation study.MHC II类肽结合凹槽在结合态、部分填充态和空态下的灵活性:分子动力学模拟研究
Biopolymers. 2009 Jan;91(1):14-27. doi: 10.1002/bip.21078.
4
Conformational alterations during biosynthesis of HLA-DR3 molecules controlled by invariant chain and HLA-DM.由恒定链和HLA-DM控制的HLA-DR3分子生物合成过程中的构象改变。
Eur J Immunol. 2001 Apr;31(4):1029-36. doi: 10.1002/1521-4141(200104)31:4<1029::aid-immu1029>3.0.co;2-q.
5
Peptide linkage to the α-subunit of MHCII creates a stably inverted antigen presentation complex.肽与 MHCII 的α亚单位连接,形成稳定的反向抗原呈递复合物。
J Mol Biol. 2012 Oct 26;423(3):294-302. doi: 10.1016/j.jmb.2012.07.008. Epub 2012 Jul 20.
6
Interaction of MHC class II molecules with the invariant chain: role of the invariant chain (81-90) region.MHC II类分子与恒定链的相互作用:恒定链(81-90)区域的作用
EMBO J. 1997 Oct 1;16(19):5807-18. doi: 10.1038/sj.emboj.7590555.
7
Studies on activities of invariant chain peptides on releasing or exchanging of antigenic peptides at human leukocyte antigen-DR1.关于恒定链肽在人白细胞抗原-DR1上释放或交换抗原肽活性的研究。
Arzneimittelforschung. 1999 Sep;49(9):791-9.
8
Point mutations in or near the antigen-binding groove of HLA-DR3 implicate class II-associated invariant chain peptide affinity as a constraint on MHC class II polymorphism.HLA - DR3抗原结合槽内或其附近的点突变表明,II类相关恒定链肽亲和力是对MHC II类多态性的一种限制。
J Immunol. 2003 May 1;170(9):4683-92. doi: 10.4049/jimmunol.170.9.4683.
9
Aberrant intermolecular disulfide bonding in a mutant HLA-DM molecule: implications for assembly, maturation, and function.突变型HLA-DM分子中异常的分子间二硫键结合:对组装、成熟和功能的影响。
J Immunol. 1998 Jan 15;160(2):734-43.
10
Editing of the HLA-DR-peptide repertoire by HLA-DM.HLA-DM对HLA-DR-肽库的编辑。
EMBO J. 1996 Nov 15;15(22):6144-54.

引用本文的文献

1
The multifaceted roles of cathepsins in immune and inflammatory responses: implications for cancer therapy, autoimmune diseases, and infectious diseases.组织蛋白酶在免疫和炎症反应中的多方面作用:对癌症治疗、自身免疫性疾病和传染病的影响。
Biomark Res. 2024 Dec 31;12(1):165. doi: 10.1186/s40364-024-00711-9.
2
A general system for targeting MHC class II-antigen complex via a single adaptable loop.一种通过单个可适配环靶向MHC II类抗原复合物的通用系统。
Nat Biotechnol. 2024 Dec 13. doi: 10.1038/s41587-024-02466-y.
3
Structural insights into human MHC-II association with invariant chain.
人类 MHC-II 与不变链结合的结构见解。
Proc Natl Acad Sci U S A. 2024 May 7;121(19):e2403031121. doi: 10.1073/pnas.2403031121. Epub 2024 Apr 30.
4
Neoself Antigens Presented on MHC Class II Molecules in Autoimmune Diseases.自身抗原在自身免疫性疾病中 MHC Ⅱ类分子上的呈递。
Adv Exp Med Biol. 2024;1444:51-65. doi: 10.1007/978-981-99-9781-7_4.
5
A general platform for targeting MHC-II antigens via a single loop.一种通过单个环靶向MHC-II抗原的通用平台。
bioRxiv. 2024 Jan 30:2024.01.26.577489. doi: 10.1101/2024.01.26.577489.
6
CD74 is expressed in a subset of pediatric acute myeloid leukemia patients and is a promising target for therapy: a report from the Children's Oncology Group.CD74 在一部分小儿急性髓系白血病患者中表达,是有治疗前景的靶点:来自儿童肿瘤协作组的报告。
Haematologica. 2024 Oct 1;109(10):3182-3193. doi: 10.3324/haematol.2023.283757.
7
Experimental validation of immunogenic SARS-CoV-2 T cell epitopes identified by artificial intelligence.人工智能鉴定的免疫原性 SARS-CoV-2 T 细胞表位的实验验证。
Front Immunol. 2023 Nov 17;14:1265044. doi: 10.3389/fimmu.2023.1265044. eCollection 2023.
8
Analysis of CD74 Occurrence in Oncogenic Fusion Proteins.分析致癌融合蛋白中 CD74 的出现情况。
Int J Mol Sci. 2023 Nov 5;24(21):15981. doi: 10.3390/ijms242115981.
9
The MHC Class II Antigen-Processing and Presentation Pathway Is Dysregulated in Type 1 Diabetes.MHC Ⅱ类抗原加工和呈递途径在 1 型糖尿病中失调。
J Immunol. 2023 Dec 1;211(11):1630-1642. doi: 10.4049/jimmunol.2300213.
10
HLA-II immunopeptidome profiling and deep learning reveal features of antigenicity to inform antigen discovery.HLA-II 免疫肽组学分析和深度学习揭示抗原性特征,为抗原发现提供信息。
Immunity. 2023 Jul 11;56(7):1681-1698.e13. doi: 10.1016/j.immuni.2023.05.009. Epub 2023 Jun 9.